Summary

The global Neurovascular Intervention Guidewire market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Neurovascular Intervention Guidewires are thin, flexible wire used in neurointerventional procedures to access and navigate through blood vessels in the brain and spinal cord. The wire is inserted through a catheter and carefully guided to the target site, serving as a pathway for placing other devices such as stents or coils.
In 2025, the North America Neurovascular Intervention Guidewire market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
Major global manufacturers of Neurovascular Intervention Guidewire include Terumo Medical, Medtronic, Abbott Laboratories, Stryker, Penumbra, Merit Medical Systems, Boston Scientific, Integer Holdings Corporation, B. Braun Melsungen, Teleflex, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Neurovascular Intervention Guidewire market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Terumo Medical
Medtronic
Abbott Laboratories
Stryker
Penumbra
Merit Medical Systems
Boston Scientific
Integer Holdings Corporation
B. Braun Melsungen
Teleflex
TE Con​​nectivity
Johnson & Johnson
Smiths Group
Asahi Intecc
Cordis Corporation
Cook Medical
Lepu Meidcal
Scientia Vascular
FMD Co., Ltd.
Sino Medical Sciences Technology Inc.
MicroPort NeuroTech
Shanghai HeartCare Medical Technology Corporation Limited
Peijia Medical
Zhejiang Medical Devices Co., Ltd. Owned By Year
Shanghai Yingtai Medical Equipment
Beijing Taijieweiye Technology
Shunmei MEDICAL
MicroVenti
Artiria Medical
Segment by Type
Solid Guide Wire
Wrapped Guide Wire
Segment by Application
Hospitals
Clinic
Other
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Neurovascular Intervention Guidewire sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Neurovascular Intervention Guidewire manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Neurovascular Intervention Guidewire product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Neurovascular Intervention Guidewire value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Neurovascular Intervention Guidewire Product Scope
1.2 Neurovascular Intervention Guidewire by Type
1.2.1 Global Neurovascular Intervention Guidewire Sales by Type (2021, 2025 & 2032)
1.2.2 Solid Guide Wire
1.2.3 Wrapped Guide Wire
1.3 Neurovascular Intervention Guidewire by Application
1.3.1 Global Neurovascular Intervention Guidewire Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Other
1.4 Global Neurovascular Intervention Guidewire Market Estimates and Forecasts (2021-2032)
1.4.1 Global Neurovascular Intervention Guidewire Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Neurovascular Intervention Guidewire Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Neurovascular Intervention Guidewire Price Trends (2021-2032)
1.5 Assumptions and Limitations

2 Market Size and Prospects by Region
2.1 Global Neurovascular Intervention Guidewire Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Neurovascular Intervention Guidewire Historical Market Scenario by Region (2021-2026)
2.2.1 Global Neurovascular Intervention Guidewire Sales Market Share by Region (2021-2026)
2.2.2 Global Neurovascular Intervention Guidewire Revenue Market Share by Region (2021-2026)
2.3 Global Neurovascular Intervention Guidewire Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Neurovascular Intervention Guidewire Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Neurovascular Intervention Guidewire Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Neurovascular Intervention Guidewire Market Size and Prospects (2021-2032)
2.4.2 Europe Neurovascular Intervention Guidewire Market Size and Prospects (2021-2032)
2.4.3 China Neurovascular Intervention Guidewire Market Size and Prospects (2021-2032)
2.4.4 Japan Neurovascular Intervention Guidewire Market Size and Prospects (2021-2032)

3 Global Market Size by Type
3.1 Global Neurovascular Intervention Guidewire Historical Market Review by Type (2021-2026)
3.1.1 Global Neurovascular Intervention Guidewire Sales by Type (2021-2026)
3.1.2 Global Neurovascular Intervention Guidewire Revenue by Type (2021-2026)
3.1.3 Global Neurovascular Intervention Guidewire Average Price by Type (2021-2026)
3.2 Global Neurovascular Intervention Guidewire Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Neurovascular Intervention Guidewire Sales Forecast by Type (2027-2032)
3.2.2 Global Neurovascular Intervention Guidewire Revenue Forecast by Type (2027-2032)
3.2.3 Global Neurovascular Intervention Guidewire Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Neurovascular Intervention Guidewire

4 Global Market Size by Application
4.1 Global Neurovascular Intervention Guidewire Historical Market Review by Application (2021-2026)
4.1.1 Global Neurovascular Intervention Guidewire Sales by Application (2021-2026)
4.1.2 Global Neurovascular Intervention Guidewire Revenue by Application (2021-2026)
4.1.3 Global Neurovascular Intervention Guidewire Average Price by Application (2021-2026)
4.2 Global Neurovascular Intervention Guidewire Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Neurovascular Intervention Guidewire Sales Forecast by Application (2027-2032)
4.2.2 Global Neurovascular Intervention Guidewire Revenue Forecast by Application (2027-2032)
4.2.3 Global Neurovascular Intervention Guidewire Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Neurovascular Intervention Guidewire Applications

5 Competition Landscape by Players
5.1 Global Neurovascular Intervention Guidewire Sales by Player (2021-2026)
5.2 Global Top Neurovascular Intervention Guidewire Players by Revenue (2021-2026)
5.3 Global Neurovascular Intervention Guidewire Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Neurovascular Intervention Guidewire revenue as of 2025
5.4 Global Neurovascular Intervention Guidewire Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Neurovascular Intervention Guidewire, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Neurovascular Intervention Guidewire, Product Type & Application
5.7 Global Key Manufacturers of Neurovascular Intervention Guidewire, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Neurovascular Intervention Guidewire Sales by Company
6.1.1.1 North America Neurovascular Intervention Guidewire Sales by Company (2021-2026)
6.1.1.2 North America Neurovascular Intervention Guidewire Revenue by Company (2021-2026)
6.1.2 North America Neurovascular Intervention Guidewire Sales Breakdown by Type (2021-2026)
6.1.3 North America Neurovascular Intervention Guidewire Sales Breakdown by Application (2021-2026)
6.1.4 North America Neurovascular Intervention Guidewire Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Neurovascular Intervention Guidewire Sales by Company
6.2.1.1 Europe Neurovascular Intervention Guidewire Sales by Company (2021-2026)
6.2.1.2 Europe Neurovascular Intervention Guidewire Revenue by Company (2021-2026)
6.2.2 Europe Neurovascular Intervention Guidewire Sales Breakdown by Type (2021-2026)
6.2.3 Europe Neurovascular Intervention Guidewire Sales Breakdown by Application (2021-2026)
6.2.4 Europe Neurovascular Intervention Guidewire Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Neurovascular Intervention Guidewire Sales by Company
6.3.1.1 China Neurovascular Intervention Guidewire Sales by Company (2021-2026)
6.3.1.2 China Neurovascular Intervention Guidewire Revenue by Company (2021-2026)
6.3.2 China Neurovascular Intervention Guidewire Sales Breakdown by Type (2021-2026)
6.3.3 China Neurovascular Intervention Guidewire Sales Breakdown by Application (2021-2026)
6.3.4 China Neurovascular Intervention Guidewire Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Neurovascular Intervention Guidewire Sales by Company
6.4.1.1 Japan Neurovascular Intervention Guidewire Sales by Company (2021-2026)
6.4.1.2 Japan Neurovascular Intervention Guidewire Revenue by Company (2021-2026)
6.4.2 Japan Neurovascular Intervention Guidewire Sales Breakdown by Type (2021-2026)
6.4.3 Japan Neurovascular Intervention Guidewire Sales Breakdown by Application (2021-2026)
6.4.4 Japan Neurovascular Intervention Guidewire Major Customers
6.4.5 Japan Market Trends and Opportunities

7 Company Profiles and Key Figures
7.1 Terumo Medical
7.1.1 Terumo Medical Company Information
7.1.2 Terumo Medical Business Overview
7.1.3 Terumo Medical Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Terumo Medical Neurovascular Intervention Guidewire Products Offered
7.1.5 Terumo Medical Recent Development
7.2 Medtronic
7.2.1 Medtronic Company Information
7.2.2 Medtronic Business Overview
7.2.3 Medtronic Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Medtronic Neurovascular Intervention Guidewire Products Offered
7.2.5 Medtronic Recent Development
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Company Information
7.3.2 Abbott Laboratories Business Overview
7.3.3 Abbott Laboratories Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Abbott Laboratories Neurovascular Intervention Guidewire Products Offered
7.3.5 Abbott Laboratories Recent Development
7.4 Stryker
7.4.1 Stryker Company Information
7.4.2 Stryker Business Overview
7.4.3 Stryker Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Stryker Neurovascular Intervention Guidewire Products Offered
7.4.5 Stryker Recent Development
7.5 Penumbra
7.5.1 Penumbra Company Information
7.5.2 Penumbra Business Overview
7.5.3 Penumbra Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Penumbra Neurovascular Intervention Guidewire Products Offered
7.5.5 Penumbra Recent Development
7.6 Merit Medical Systems
7.6.1 Merit Medical Systems Company Information
7.6.2 Merit Medical Systems Business Overview
7.6.3 Merit Medical Systems Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Merit Medical Systems Neurovascular Intervention Guidewire Products Offered
7.6.5 Merit Medical Systems Recent Development
7.7 Boston Scientific
7.7.1 Boston Scientific Company Information
7.7.2 Boston Scientific Business Overview
7.7.3 Boston Scientific Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Boston Scientific Neurovascular Intervention Guidewire Products Offered
7.7.5 Boston Scientific Recent Development
7.8 Integer Holdings Corporation
7.8.1 Integer Holdings Corporation Company Information
7.8.2 Integer Holdings Corporation Business Overview
7.8.3 Integer Holdings Corporation Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Integer Holdings Corporation Neurovascular Intervention Guidewire Products Offered
7.8.5 Integer Holdings Corporation Recent Development
7.9 B. Braun Melsungen
7.9.1 B. Braun Melsungen Company Information
7.9.2 B. Braun Melsungen Business Overview
7.9.3 B. Braun Melsungen Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.9.4 B. Braun Melsungen Neurovascular Intervention Guidewire Products Offered
7.9.5 B. Braun Melsungen Recent Development
7.10 Teleflex
7.10.1 Teleflex Company Information
7.10.2 Teleflex Business Overview
7.10.3 Teleflex Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.10.4 Teleflex Neurovascular Intervention Guidewire Products Offered
7.10.5 Teleflex Recent Development
7.11 TE Con​​nectivity
7.11.1 TE Con​​nectivity Company Information
7.11.2 TE Con​​nectivity Business Overview
7.11.3 TE Con​​nectivity Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.11.4 TE Con​​nectivity Neurovascular Intervention Guidewire Products Offered
7.11.5 TE Con​​nectivity Recent Development
7.12 Johnson & Johnson
7.12.1 Johnson & Johnson Company Information
7.12.2 Johnson & Johnson Business Overview
7.12.3 Johnson & Johnson Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.12.4 Johnson & Johnson Neurovascular Intervention Guidewire Products Offered
7.12.5 Johnson & Johnson Recent Development
7.13 Smiths Group
7.13.1 Smiths Group Company Information
7.13.2 Smiths Group Business Overview
7.13.3 Smiths Group Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.13.4 Smiths Group Neurovascular Intervention Guidewire Products Offered
7.13.5 Smiths Group Recent Development
7.14 Asahi Intecc
7.14.1 Asahi Intecc Company Information
7.14.2 Asahi Intecc Business Overview
7.14.3 Asahi Intecc Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.14.4 Asahi Intecc Neurovascular Intervention Guidewire Products Offered
7.14.5 Asahi Intecc Recent Development
7.15 Cordis Corporation
7.15.1 Cordis Corporation Company Information
7.15.2 Cordis Corporation Business Overview
7.15.3 Cordis Corporation Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.15.4 Cordis Corporation Neurovascular Intervention Guidewire Products Offered
7.15.5 Cordis Corporation Recent Development
7.16 Cook Medical
7.16.1 Cook Medical Company Information
7.16.2 Cook Medical Business Overview
7.16.3 Cook Medical Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.16.4 Cook Medical Neurovascular Intervention Guidewire Products Offered
7.16.5 Cook Medical Recent Development
7.17 Lepu Meidcal
7.17.1 Lepu Meidcal Company Information
7.17.2 Lepu Meidcal Business Overview
7.17.3 Lepu Meidcal Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.17.4 Lepu Meidcal Neurovascular Intervention Guidewire Products Offered
7.17.5 Lepu Meidcal Recent Development
7.18 Scientia Vascular
7.18.1 Scientia Vascular Company Information
7.18.2 Scientia Vascular Business Overview
7.18.3 Scientia Vascular Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.18.4 Scientia Vascular Neurovascular Intervention Guidewire Products Offered
7.18.5 Scientia Vascular Recent Development
7.19 FMD Co., Ltd.
7.19.1 FMD Co., Ltd. Company Information
7.19.2 FMD Co., Ltd. Business Overview
7.19.3 FMD Co., Ltd. Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.19.4 FMD Co., Ltd. Neurovascular Intervention Guidewire Products Offered
7.19.5 FMD Co., Ltd. Recent Development
7.20 Sino Medical Sciences Technology Inc.
7.20.1 Sino Medical Sciences Technology Inc. Company Information
7.20.2 Sino Medical Sciences Technology Inc. Business Overview
7.20.3 Sino Medical Sciences Technology Inc. Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.20.4 Sino Medical Sciences Technology Inc. Neurovascular Intervention Guidewire Products Offered
7.20.5 Sino Medical Sciences Technology Inc. Recent Development
7.21 MicroPort NeuroTech
7.21.1 MicroPort NeuroTech Company Information
7.21.2 MicroPort NeuroTech Business Overview
7.21.3 MicroPort NeuroTech Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.21.4 MicroPort NeuroTech Neurovascular Intervention Guidewire Products Offered
7.21.5 MicroPort NeuroTech Recent Development
7.22 Shanghai HeartCare Medical Technology Corporation Limited
7.22.1 Shanghai HeartCare Medical Technology Corporation Limited Company Information
7.22.2 Shanghai HeartCare Medical Technology Corporation Limited Business Overview
7.22.3 Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.22.4 Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Intervention Guidewire Products Offered
7.22.5 Shanghai HeartCare Medical Technology Corporation Limited Recent Development
7.23 Peijia Medical
7.23.1 Peijia Medical Company Information
7.23.2 Peijia Medical Business Overview
7.23.3 Peijia Medical Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.23.4 Peijia Medical Neurovascular Intervention Guidewire Products Offered
7.23.5 Peijia Medical Recent Development
7.24 Zhejiang Medical Devices Co., Ltd. Owned By Year
7.24.1 Zhejiang Medical Devices Co., Ltd. Owned By Year Company Information
7.24.2 Zhejiang Medical Devices Co., Ltd. Owned By Year Business Overview
7.24.3 Zhejiang Medical Devices Co., Ltd. Owned By Year Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.24.4 Zhejiang Medical Devices Co., Ltd. Owned By Year Neurovascular Intervention Guidewire Products Offered
7.24.5 Zhejiang Medical Devices Co., Ltd. Owned By Year Recent Development
7.25 Shanghai Yingtai Medical Equipment
7.25.1 Shanghai Yingtai Medical Equipment Company Information
7.25.2 Shanghai Yingtai Medical Equipment Business Overview
7.25.3 Shanghai Yingtai Medical Equipment Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.25.4 Shanghai Yingtai Medical Equipment Neurovascular Intervention Guidewire Products Offered
7.25.5 Shanghai Yingtai Medical Equipment Recent Development
7.26 Beijing Taijieweiye Technology
7.26.1 Beijing Taijieweiye Technology Company Information
7.26.2 Beijing Taijieweiye Technology Business Overview
7.26.3 Beijing Taijieweiye Technology Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.26.4 Beijing Taijieweiye Technology Neurovascular Intervention Guidewire Products Offered
7.26.5 Beijing Taijieweiye Technology Recent Development
7.27 Shunmei MEDICAL
7.27.1 Shunmei MEDICAL Company Information
7.27.2 Shunmei MEDICAL Business Overview
7.27.3 Shunmei MEDICAL Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.27.4 Shunmei MEDICAL Neurovascular Intervention Guidewire Products Offered
7.27.5 Shunmei MEDICAL Recent Development
7.28 MicroVenti
7.28.1 MicroVenti Company Information
7.28.2 MicroVenti Business Overview
7.28.3 MicroVenti Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.28.4 MicroVenti Neurovascular Intervention Guidewire Products Offered
7.28.5 MicroVenti Recent Development
7.29 Artiria Medical
7.29.1 Artiria Medical Company Information
7.29.2 Artiria Medical Business Overview
7.29.3 Artiria Medical Neurovascular Intervention Guidewire Sales, Revenue and Gross Margin (2021-2026)
7.29.4 Artiria Medical Neurovascular Intervention Guidewire Products Offered
7.29.5 Artiria Medical Recent Development

8 Neurovascular Intervention Guidewire Manufacturing Cost Analysis
8.1 Neurovascular Intervention Guidewire Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Neurovascular Intervention Guidewire
8.4 Neurovascular Intervention Guidewire Industrial Chain Analysis

9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Neurovascular Intervention Guidewire Distributors List
9.3 Neurovascular Intervention Guidewire Customers

10 Neurovascular Intervention Guidewire Market Dynamics
10.1 Neurovascular Intervention Guidewire Industry Trends
10.2 Neurovascular Intervention Guidewire Market Drivers
10.3 Neurovascular Intervention Guidewire Market Challenges
10.4 Neurovascular Intervention Guidewire Market Restraints

11 Research Findings and Conclusion

12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Neurovascular Intervention Guidewire Sales (US$ Million) Growth Rate by Type (2021, 2025 & 2032)
Table 2. Global Neurovascular Intervention Guidewire Sales (US$ Million) Comparison by Application (2021, 2025 & 2032)
Table 3. Global Market Neurovascular Intervention Guidewire Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Table 4. Global Neurovascular Intervention Guidewire Sales (K Units) by Region (2021-2026)
Table 5. Global Neurovascular Intervention Guidewire Sales Market Share by Region (2021-2026)
Table 6. Global Neurovascular Intervention Guidewire Revenue (US$ Million) Market Share by Region (2021-2026)
Table 7. Global Neurovascular Intervention Guidewire Revenue Share by Region (2021-2026)
Table 8. Global Neurovascular Intervention Guidewire Sales (K Units) Forecast by Region (2027-2032)
Table 9. Global Neurovascular Intervention Guidewire Sales Market Share Forecast by Region (2027-2032)
Table 10. Global Neurovascular Intervention Guidewire Revenue (US$ Million) Forecast by Region (2027-2032)
Table 11. Global Neurovascular Intervention Guidewire Revenue Share Forecast by Region (2027-2032)
Table 12. Global Neurovascular Intervention Guidewire Sales by Type (K Units) & (2021-2026)
Table 13. Global Neurovascular Intervention Guidewire Sales Share by Type (2021-2026)
Table 14. Global Neurovascular Intervention Guidewire Revenue by Type (US$ Million) & (2021-2026)
Table 15. Global Neurovascular Intervention Guidewire Average Price by Type (US$/Unit) & (2021-2026)
Table 16. Global Neurovascular Intervention Guidewire Sales by Type (K Units) & (2027-2032)
Table 17. Global Neurovascular Intervention Guidewire Revenue by Type (US$ Million) & (2027-2032)
Table 18. Global Neurovascular Intervention Guidewire Average Price by Type (US$/Unit) & (2027-2032)
Table 19. Representative Players of Each Type
Table 20. Global Neurovascular Intervention Guidewire Sales by Application (K Units) & (2021-2026)
Table 21. Global Neurovascular Intervention Guidewire Sales Share by Application (2021-2026)
Table 22. Global Neurovascular Intervention Guidewire Revenue by Application (US$ Million) & (2021-2026)
Table 23. Global Neurovascular Intervention Guidewire Average Price by Application (US$/Unit) & (2021-2026)
Table 24. Global Neurovascular Intervention Guidewire Sales by Application (K Units) & (2027-2032)
Table 25. Global Neurovascular Intervention Guidewire Revenue Market Share by Application (US$ Million) & (2027-2032)
Table 26. Global Neurovascular Intervention Guidewire Average Price by Application (US$/Unit) & (2027-2032)
Table 27. New Sources of Growth in Neurovascular Intervention Guidewire Applications
Table 28. Global Neurovascular Intervention Guidewire Sales by Company (K Units) & (2021-2026)
Table 29. Global Neurovascular Intervention Guidewire Sales Share by Company (2021-2026)
Table 30. Global Neurovascular Intervention Guidewire Revenue by Company (US$ Million) & (2021-2026)
Table 31. Global Neurovascular Intervention Guidewire Revenue Share by Company (2021-2026)
Table 32. Global Neurovascular Intervention Guidewire by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurovascular Intervention Guidewire as of 2025)
Table 33. Global Market Neurovascular Intervention Guidewire Average Price by Company (US$/Unit) & (2021-2026)
Table 34. Global Key Manufacturers of Neurovascular Intervention Guidewire, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Neurovascular Intervention Guidewire, Product Type & Application
Table 36. Global Key Manufacturers of Neurovascular Intervention Guidewire, Date of Entry into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Neurovascular Intervention Guidewire Sales by Company (2021-2026) & (K Units)
Table 39. North America Neurovascular Intervention Guidewire Sales Market Share by Company (2021-2026)
Table 40. North America Neurovascular Intervention Guidewire Revenue by Company (2021-2026) & (US$ Million)
Table 41. North America Neurovascular Intervention Guidewire Revenue Market Share by Company (2021-2026)
Table 42. North America Neurovascular Intervention Guidewire Sales by Type (2021-2026) & (K Units)
Table 43. North America Neurovascular Intervention Guidewire Sales Market Share by Type (2021-2026)
Table 44. North America Neurovascular Intervention Guidewire Sales by Application (2021-2026) & (K Units)
Table 45. North America Neurovascular Intervention Guidewire Sales Market Share by Application (2021-2026)
Table 46. Europe Neurovascular Intervention Guidewire Sales by Company (2021-2026) & (K Units)
Table 47. Europe Neurovascular Intervention Guidewire Sales Market Share by Company (2021-2026)
Table 48. Europe Neurovascular Intervention Guidewire Revenue by Company (2021-2026) & (US$ Million)
Table 49. Europe Neurovascular Intervention Guidewire Revenue Market Share by Company (2021-2026)
Table 50. Europe Neurovascular Intervention Guidewire Sales by Type (2021-2026) & (K Units)
Table 51. Europe Neurovascular Intervention Guidewire Sales Market Share by Type (2021-2026)
Table 52. Europe Neurovascular Intervention Guidewire Sales by Application (2021-2026) & (K Units)
Table 53. Europe Neurovascular Intervention Guidewire Sales Market Share by Application (2021-2026)
Table 54. China Neurovascular Intervention Guidewire Sales by Company (2021-2026) & (K Units)
Table 55. China Neurovascular Intervention Guidewire Sales Market Share by Company (2021-2026)
Table 56. China Neurovascular Intervention Guidewire Revenue by Company (2021-2026) & (US$ Million)
Table 57. China Neurovascular Intervention Guidewire Revenue Market Share by Company (2021-2026)
Table 58. China Neurovascular Intervention Guidewire Sales by Type (2021-2026) & (K Units)
Table 59. China Neurovascular Intervention Guidewire Sales Market Share by Type (2021-2026)
Table 60. China Neurovascular Intervention Guidewire Sales by Application (2021-2026) & (K Units)
Table 61. China Neurovascular Intervention Guidewire Sales Market Share by Application (2021-2026)
Table 62. Japan Neurovascular Intervention Guidewire Sales by Company (2021-2026) & (K Units)
Table 63. Japan Neurovascular Intervention Guidewire Sales Market Share by Company (2021-2026)
Table 64. Japan Neurovascular Intervention Guidewire Revenue by Company (2021-2026) & (US$ Million)
Table 65. Japan Neurovascular Intervention Guidewire Revenue Market Share by Company (2021-2026)
Table 66. Japan Neurovascular Intervention Guidewire Sales by Type (2021-2026) & (K Units)
Table 67. Japan Neurovascular Intervention Guidewire Sales Market Share by Type (2021-2026)
Table 68. Japan Neurovascular Intervention Guidewire Sales by Application (2021-2026) & (K Units)
Table 69. Japan Neurovascular Intervention Guidewire Sales Market Share by Application (2021-2026)
Table 70. Terumo Medical Company Information
Table 71. Terumo Medical Description and Business Overview
Table 72. Terumo Medical Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 73. Terumo Medical Neurovascular Intervention Guidewire Product
Table 74. Terumo Medical Recent Development
Table 75. Medtronic Company Information
Table 76. Medtronic Description and Business Overview
Table 77. Medtronic Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Medtronic Neurovascular Intervention Guidewire Product
Table 79. Medtronic Recent Development
Table 80. Abbott Laboratories Company Information
Table 81. Abbott Laboratories Description and Business Overview
Table 82. Abbott Laboratories Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Abbott Laboratories Neurovascular Intervention Guidewire Product
Table 84. Abbott Laboratories Recent Development
Table 85. Stryker Company Information
Table 86. Stryker Description and Business Overview
Table 87. Stryker Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Stryker Neurovascular Intervention Guidewire Product
Table 89. Stryker Recent Development
Table 90. Penumbra Company Information
Table 91. Penumbra Description and Business Overview
Table 92. Penumbra Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Penumbra Neurovascular Intervention Guidewire Product
Table 94. Penumbra Recent Development
Table 95. Merit Medical Systems Company Information
Table 96. Merit Medical Systems Description and Business Overview
Table 97. Merit Medical Systems Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Merit Medical Systems Neurovascular Intervention Guidewire Product
Table 99. Merit Medical Systems Recent Development
Table 100. Boston Scientific Company Information
Table 101. Boston Scientific Description and Business Overview
Table 102. Boston Scientific Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Boston Scientific Neurovascular Intervention Guidewire Product
Table 104. Boston Scientific Recent Development
Table 105. Integer Holdings Corporation Company Information
Table 106. Integer Holdings Corporation Description and Business Overview
Table 107. Integer Holdings Corporation Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Integer Holdings Corporation Neurovascular Intervention Guidewire Product
Table 109. Integer Holdings Corporation Recent Development
Table 110. B. Braun Melsungen Company Information
Table 111. B. Braun Melsungen Description and Business Overview
Table 112. B. Braun Melsungen Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. B. Braun Melsungen Neurovascular Intervention Guidewire Product
Table 114. B. Braun Melsungen Recent Development
Table 115. Teleflex Company Information
Table 116. Teleflex Description and Business Overview
Table 117. Teleflex Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Teleflex Neurovascular Intervention Guidewire Product
Table 119. Teleflex Recent Development
Table 120. TE Con​​nectivity Company Information
Table 121. TE Con​​nectivity Description and Business Overview
Table 122. TE Con​​nectivity Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. TE Con​​nectivity Neurovascular Intervention Guidewire Product
Table 124. TE Con​​nectivity Recent Development
Table 125. Johnson & Johnson Company Information
Table 126. Johnson & Johnson Description and Business Overview
Table 127. Johnson & Johnson Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Johnson & Johnson Neurovascular Intervention Guidewire Product
Table 129. Johnson & Johnson Recent Development
Table 130. Smiths Group Company Information
Table 131. Smiths Group Description and Business Overview
Table 132. Smiths Group Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Smiths Group Neurovascular Intervention Guidewire Product
Table 134. Smiths Group Recent Development
Table 135. Asahi Intecc Company Information
Table 136. Asahi Intecc Description and Business Overview
Table 137. Asahi Intecc Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. Asahi Intecc Neurovascular Intervention Guidewire Product
Table 139. Asahi Intecc Recent Development
Table 140. Cordis Corporation Company Information
Table 141. Cordis Corporation Description and Business Overview
Table 142. Cordis Corporation Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. Cordis Corporation Neurovascular Intervention Guidewire Product
Table 144. Cordis Corporation Recent Development
Table 145. Cook Medical Company Information
Table 146. Cook Medical Description and Business Overview
Table 147. Cook Medical Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. Cook Medical Neurovascular Intervention Guidewire Product
Table 149. Cook Medical Recent Development
Table 150. Lepu Meidcal Company Information
Table 151. Lepu Meidcal Description and Business Overview
Table 152. Lepu Meidcal Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. Lepu Meidcal Neurovascular Intervention Guidewire Product
Table 154. Lepu Meidcal Recent Development
Table 155. Scientia Vascular Company Information
Table 156. Scientia Vascular Description and Business Overview
Table 157. Scientia Vascular Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 158. Scientia Vascular Neurovascular Intervention Guidewire Product
Table 159. Scientia Vascular Recent Development
Table 160. FMD Co., Ltd. Company Information
Table 161. FMD Co., Ltd. Description and Business Overview
Table 162. FMD Co., Ltd. Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 163. FMD Co., Ltd. Neurovascular Intervention Guidewire Product
Table 164. FMD Co., Ltd. Recent Development
Table 165. Sino Medical Sciences Technology Inc. Company Information
Table 166. Sino Medical Sciences Technology Inc. Description and Business Overview
Table 167. Sino Medical Sciences Technology Inc. Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 168. Sino Medical Sciences Technology Inc. Neurovascular Intervention Guidewire Product
Table 169. Sino Medical Sciences Technology Inc. Recent Development
Table 170. MicroPort NeuroTech Company Information
Table 171. MicroPort NeuroTech Description and Business Overview
Table 172. MicroPort NeuroTech Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 173. MicroPort NeuroTech Neurovascular Intervention Guidewire Product
Table 174. MicroPort NeuroTech Recent Development
Table 175. Shanghai HeartCare Medical Technology Corporation Limited Company Information
Table 176. Shanghai HeartCare Medical Technology Corporation Limited Description and Business Overview
Table 177. Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 178. Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Intervention Guidewire Product
Table 179. Shanghai HeartCare Medical Technology Corporation Limited Recent Development
Table 180. Peijia Medical Company Information
Table 181. Peijia Medical Description and Business Overview
Table 182. Peijia Medical Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 183. Peijia Medical Neurovascular Intervention Guidewire Product
Table 184. Peijia Medical Recent Development
Table 185. Zhejiang Medical Devices Co., Ltd. Owned By Year Company Information
Table 186. Zhejiang Medical Devices Co., Ltd. Owned By Year Description and Business Overview
Table 187. Zhejiang Medical Devices Co., Ltd. Owned By Year Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 188. Zhejiang Medical Devices Co., Ltd. Owned By Year Neurovascular Intervention Guidewire Product
Table 189. Zhejiang Medical Devices Co., Ltd. Owned By Year Recent Development
Table 190. Shanghai Yingtai Medical Equipment Company Information
Table 191. Shanghai Yingtai Medical Equipment Description and Business Overview
Table 192. Shanghai Yingtai Medical Equipment Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 193. Shanghai Yingtai Medical Equipment Neurovascular Intervention Guidewire Product
Table 194. Shanghai Yingtai Medical Equipment Recent Development
Table 195. Beijing Taijieweiye Technology Company Information
Table 196. Beijing Taijieweiye Technology Description and Business Overview
Table 197. Beijing Taijieweiye Technology Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 198. Beijing Taijieweiye Technology Neurovascular Intervention Guidewire Product
Table 199. Beijing Taijieweiye Technology Recent Development
Table 200. Shunmei MEDICAL Company Information
Table 201. Shunmei MEDICAL Description and Business Overview
Table 202. Shunmei MEDICAL Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 203. Shunmei MEDICAL Neurovascular Intervention Guidewire Product
Table 204. Shunmei MEDICAL Recent Development
Table 205. MicroVenti Company Information
Table 206. MicroVenti Description and Business Overview
Table 207. MicroVenti Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 208. MicroVenti Neurovascular Intervention Guidewire Product
Table 209. MicroVenti Recent Development
Table 210. Artiria Medical Company Information
Table 211. Artiria Medical Description and Business Overview
Table 212. Artiria Medical Neurovascular Intervention Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 213. Artiria Medical Neurovascular Intervention Guidewire Product
Table 214. Artiria Medical Recent Development
Table 215. Production Base and Market Concentration Rate of Raw Material
Table 216. Key Suppliers of Raw Materials
Table 217. Neurovascular Intervention Guidewire Distributors List
Table 218. Neurovascular Intervention Guidewire Customers List
Table 219. Neurovascular Intervention Guidewire Market Trends
Table 220. Neurovascular Intervention Guidewire Market Drivers
Table 221. Neurovascular Intervention Guidewire Market Challenges
Table 222. Neurovascular Intervention Guidewire Market Restraints
Table 223. Research Programs/Design for This Report
Table 224. Key Data Information from Secondary Sources
Table 225. Key Data Information from Primary Sources

List of Figures
Figure 1. Neurovascular Intervention Guidewire Product Picture
Figure 2. Global Neurovascular Intervention Guidewire Sales (US$ Million) by Type (2021, 2025 & 2032)
Figure 3. Global Neurovascular Intervention Guidewire Sales Market Share by Type in 2025 & 2032
Figure 4. Solid Guide Wire Product Picture
Figure 5. Wrapped Guide Wire Product Picture
Figure 6. Global Neurovascular Intervention Guidewire Sales (US$ Million) by Application (2021, 2025 & 2032)
Figure 7. Global Neurovascular Intervention Guidewire Sales Market Share by Application in 2025 & 2032
Figure 8. Hospitals Examples
Figure 9. Clinic Examples
Figure 10. Other Examples
Figure 11. Global Neurovascular Intervention Guidewire Sales, (US$ Million), 2021 VS 2025 VS 2032
Figure 12. Global Neurovascular Intervention Guidewire Sales Growth Rate (2021-2032) & (US$ Million)
Figure 13. Global Neurovascular Intervention Guidewire Sales (K Units) Growth Rate (2021-2032)
Figure 14. Global Neurovascular Intervention Guidewire Price Trends Growth Rate (2021-2032) & (US$/Unit)
Figure 15. Neurovascular Intervention Guidewire Report Years Considered
Figure 16. Global Market Neurovascular Intervention Guidewire Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Figure 17. Global Neurovascular Intervention Guidewire Revenue Market Share by Region: 2021 VS 2025
Figure 18. North America Neurovascular Intervention Guidewire Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. North America Neurovascular Intervention Guidewire Sales (K Units) Growth Rate (2021-2032)
Figure 20. Europe Neurovascular Intervention Guidewire Revenue (US$ Million) Growth Rate (2021-2032)
Figure 21. Europe Neurovascular Intervention Guidewire Sales (K Units) Growth Rate (2021-2032)
Figure 22. China Neurovascular Intervention Guidewire Revenue (US$ Million) Growth Rate (2021-2032)
Figure 23. China Neurovascular Intervention Guidewire Sales (K Units) Growth Rate (2021-2032)
Figure 24. Japan Neurovascular Intervention Guidewire Revenue (US$ Million) Growth Rate (2021-2032)
Figure 25. Japan Neurovascular Intervention Guidewire Sales (K Units) Growth Rate (2021-2032)
Figure 26. Global Neurovascular Intervention Guidewire Revenue Share by Type (2021-2026)
Figure 27. Global Neurovascular Intervention Guidewire Sales Share by Type (2027-2032)
Figure 28. Global Neurovascular Intervention Guidewire Revenue Share by Type (2027-2032)
Figure 29. Global Neurovascular Intervention Guidewire Revenue Share by Application (2021-2026)
Figure 30. Global Neurovascular Intervention Guidewire Revenue Market Share by Application in 2021 & 2025
Figure 31. Global Neurovascular Intervention Guidewire Sales Share by Application (2027-2032)
Figure 32. Global Neurovascular Intervention Guidewire Revenue Share by Application (2027-2032)
Figure 33. Global Neurovascular Intervention Guidewire Sales Share by Company (2025)
Figure 34. Global Neurovascular Intervention Guidewire Revenue Share by Company (2025)
Figure 35. Global 5 Largest Neurovascular Intervention Guidewire Players Market Share by Revenue in Neurovascular Intervention Guidewire: 2021 & 2025
Figure 36. Neurovascular Intervention Guidewire Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 37. Manufacturing Cost Structure of Neurovascular Intervention Guidewire
Figure 38. Manufacturing Process Analysis of Neurovascular Intervention Guidewire
Figure 39. Neurovascular Intervention Guidewire Industrial Chain
Figure 40. Channels of Distribution (Direct Vs Distribution)
Figure 41. Distributors Profiles
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed